Differential response to treatment of relapsing–remitting multiple sclerosis with IFN-&bgr;: is there a dichotomy into T-helper-1 and -17 driven disease?

Author： Weissert Robert  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.5, Iss.4, 2010-07, pp. : 481-484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis

By  

Brain And Behavior, Vol. 8, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

By Hirst C.   Pace A.   Pickersgill T.   Jones R.   McLean B.   Zajicek J.   Scolding N.   Robertson N.  

Journal of Neurology, Vol. 255, Iss. 2, 2008-02 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Development of laquinimod for relapsing––remitting multiple sclerosis

By Jeffery Douglas R  

Future Neurology, Vol. 3, Iss. 6, 2008-11 ,pp. : 641-648

Future Medicine

Access to resources Recommend Favorite

Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

By Sladkova Vladimira   Mareš Jan   Lubenova Blanka   Zapletalova Jana   Stejskal David   Hlustik Petr   Kanovsky Petr  

Neurological Research, Vol. 33, Iss. 4, 2011-05 ,pp. : 415-420

Maney Publishing

Access to resources Recommend Favorite

Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis

By Passamonti Luca  

Brain, Vol. 132, Iss. 12, 2009-12 ,pp. : 3380-3391

Oxford University Press

Access to resources Recommend Favorite